|4Dec 6, 5:48 PM ET

Berger Mark Stanley 4

4 · Genprex, Inc. · Filed Dec 6, 2024

Insider Transaction Report

Form 4
Period: 2024-12-05
Berger Mark Stanley
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2024-12-05+18,25023,056 total
Footnotes (1)
  • [F1]This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan and vests 100% as of June 30, 2025, provided that the recipient continues to serve as a Service Provider (as defined in the Company's 2018 Equity Incentive Plan) through the applicable vesting date. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4